← The impacts · AItopiaOrAImageddon?
entry · p2026-09-06-219 · validated
ARDA (Google/Verily Automated Retinal Disease Assessment), India
screening 600 000 patients in India
- tech
- arda-dr-screening
- passes the definition as
- a deep-learning fundus-image grader fit to adjudicated retinal photographs, grading diabetic retinopathy severity
- from
- 2019-01-01
- region
- IN
- domain
- health
- side
- benefit
- people
- 600,000 patients screened (2023-07-31)
- effect
- 0 percent (2023-07-31) — clinically important miss rate of 0% for severe NPDR or PDR, at 97.0% sensitivity and 96.4% specificity, in the first large-scale post-marketing evaluation
- reversible
- yes
- who holds the switch
- owner:Google/Verily and Aravind Eye Hospitals
- attribution
- named
- source kind
- primary
- the statistic
- ARDA screened 600,000 patients across 45 sites in southern India; in a random sample drawn between 1 January 2019 and 31 July 2023 with 4,537 evaluable images, sensitivity for severe NPDR or PDR was 97.0% (95% CI 92.6-99.2) and specificity 96.4% (95.7-97.0), and the clinically important miss rate for severe NPDR or PDR was 0%.
- source
- https://research.google/pubs/performance-of-a-deep-learning-diabetic-retinopathy-algorithm-in-india/
- proposed by
- researcher (opus), brief 2026-09-06 second harvest, china-india-africa-latam
- received
- 2026-09-06T10:20:12-04:00
- harvest report
- impacts/harvest/2026-09-06-china-india-africa-latam.md
Rulings, in order
- 2026-09-06T10:21:26-04:00 · validatorpass — quote found on the fetched page (exact match; HTTP 200 text/html; charset=utf-8)
- 2026-09-06T10:21:26-04:00 · sessionseverity — a diagnosis in service at 600,000 patients, 0% clinically important miss rate
The proposal as it arrived (JSON)
{
"id": "p2026-09-06-219",
"received": "2026-09-06T10:20:12-04:00",
"proposer": "researcher (opus), brief 2026-09-06 second harvest, china-india-africa-latam",
"kind": "entry",
"sha": "3e57cf78e9c05f19",
"data": {
"kind": "entry",
"tech": "arda-dr-screening",
"tech_name": "ARDA (Google/Verily Automated Retinal Disease Assessment), India",
"definition": "a deep-learning fundus-image grader fit to adjudicated retinal photographs, grading diabetic retinopathy severity",
"from": "2019-01-01",
"region": "IN",
"domain": "health",
"side": "benefit",
"people": {
"n": 600000,
"unit": "patients screened",
"date": "2023-07-31"
},
"effect": {
"n": 0,
"unit": "percent",
"date": "2023-07-31",
"what": "clinically important miss rate of 0% for severe NPDR or PDR, at 97.0% sensitivity and 96.4% specificity, in the first large-scale post-marketing evaluation"
},
"reversible": true,
"switch": "owner:Google/Verily and Aravind Eye Hospitals",
"statistic": "ARDA screened 600,000 patients across 45 sites in southern India; in a random sample drawn between 1 January 2019 and 31 July 2023 with 4,537 evaluable images, sensitivity for severe NPDR or PDR was 97.0% (95% CI 92.6-99.2) and specificity 96.4% (95.7-97.0), and the clinically important miss rate for severe NPDR or PDR was 0%.",
"source": "https://research.google/pubs/performance-of-a-deep-learning-diabetic-retinopathy-algorithm-in-india/",
"quote": "screening 600 000 patients in India",
"attribution": "named",
"source_kind": "primary"
},
"from_file": "impacts/harvest/2026-09-06-china-india-africa-latam.md"
}